Day: July 29, 2022

JAKARTA, Indonesia, July 29, 2022 /PRNewswire/ — PT Dayamitra Telekomunikasi Tbk (IDX: MTEL) or Mitratel, recorded a revenue of IDR 3.72 trillion in H1 2022, increasing 15.5% compared to H1 2021. This also contributed to the company’s net profit soaring 27.2% to IDR 892 billion.

“In H1 2022 post-IPO, we had solid fundamentals for sustainable growth driven by organic growth strategy, strong revenue from tower-related businesses, product innovations, and cost efficiency,” said Mitratel President Director Theodorus Ardi Hartoko, better known as Teddy Hartoko.

The earnings before interest, taxes, depreciation, and amortization (EBITDA) and net profit margins in H1 2022 increased to 77.5% and 23.9%, respectively, with the EBITDA margin of tower rental portfolios increasing to 85.2% as the main contributor. This was achieved by cost efficiency and selecting revenue from businesses with higher margins for higher profitability in the industry.

In H1 2022, most revenue contributions came from tower rental incomes, which grew 13.5% from IDR 2.93 trillion to IDR 3.33 trillion, as well as other tower-related businesses, which increased 35.4% to IDR 399 billion.

The number of towers owned by Mitratel in H1 2022 reached 28,787, with 5,555 additional towers or 23.9% growth from H1 2021. The number of tenants increased by 20.3%, from 36,507 tenants to 43,900 tenants.

The company’s total asset was recorded at IDR 55.06 trillion, with equity of IDR 33.49 trillion. Total liabilities in H1 2022 decreased by 10.4% to IDR 21.56 trillion, in line with the payment of long-term loans worth IDR 5.1 trillion, including early payment of IDR 4.3 trillion long-term debts using excess cash from operating activities and refinance loans at lower interest rates.

Mitratel is a telecommunications tower company consisting of the largest tower and number of subscribers growth in 2017 to 2021. Mitratel’s biggest anchor customer, Telkomsel, has the largest cellular operator and the best credit rating. This gives telecommunication operators and non-operator tenants a chance to expand their service coverage to include other supporting businesses. Furthermore, Mitratel has no risk to foreign currency fluctuations as all loans are in Indonesian Rupiah. The debt to equity and net debt to EBITDA ratios were maintained at 44.3% and -0.4x.

Going forward, Mitratel will continue with its strategic initiatives to maintain its position in the market, strengthen new business portfolios, accelerate inorganic growth targeting 6,000 towers this year, and increase profitability and cash flow through cost efficiency.

“We are targeting an EBITDA margin of more than 80% in this medium-term through a series of programs that facilitate telecommunication operators in Indonesia to expand the reach using the collocation of Mitratel towers. We have prepared well-rounded solutions with attractive a business scheme for all telecommunication operators namely by bundling solutions such as tower, connectivity, and power. The connectivity includes fiber access (dark fiber, capacity leased, and hybrid) and non-fiber access (satellite). With these innovative product solutions, Mitratel aims to provide convenience to all operators to develop telecommunication networks throughout Indonesia, especially outside Java,” concluded Theodorus.

*Click here for image assets

NEW YORK, July 29, 2022 /PRNewswire/ — Paramount Global (NASDAQ: PARA, PARAA) today announced that Pamela Kaufman, President of Global Consumer Products and Experiences for Paramount, has been appointed President and CEO of International Markets, Global Consumer Products & Experiences, effective immediately. This newly created position reports to Bob Bakish, President and CEO of Paramount, and reflects Paramount’s ongoing strategy of globalizing its operations. Raffaele Annecchino has decided to leave the company in his role as President and CEO of Paramount International Networks, Studios and Streaming.

In her expanded role, Kaufman will be responsible for driving the continued growth of Paramount’s international business and ensuring the strength of the company’s international operations across six continents, including broadcast and cable networks, streaming and studios, and the Company’s commercial capabilities. She will work closely with Paramount’s international leadership team, as well as the global content and streaming organization to do so, including helping to guide the continued international rollout of Paramount+ and Pluto TV. Kaufman will maintain her current responsibilities overseeing the global multi-billion-dollar consumer products and experiences organization.

“Pam has been the strategic force behind growing and expanding some of the most iconic global franchises and properties in entertainment,” said Bakish. “She is a proven and trusted, visionary leader who has transformed our consumer products organization by driving innovation and operating as a global business. Pam is uniquely qualified to lead our international business as we expand and diversify our worldwide footprint and accelerate Paramount’s transformation to operating with a truly global approach.”

Bakish added, “I want to extend my thanks to Raffaele Annecchino for the critical role he has played in building Paramount’s international business and expanding our global footprint. I am grateful for the dedication he has shown throughout his 25 years at Paramount and wish him well in the future.”

“I am honored to take on this role at such a pivotal time for Paramount’s international business,” said Kaufman. “I know firsthand the global strength of our brand portfolio, and I look forward to working with Bob and the incredible International team as we continue pursuing our global growth strategy, investing in key partnerships, furthering our push into mobile and digital platforms in new markets, and operating as one team globally.”

In November 2021, Kaufman assumed the role of President of Global Consumer Products and Experiences for Paramount, overseeing worldwide product and business development, marketing, franchise planning, creative strategy, retail sales and consumer insights for all brands in the portfolio. In less than a year, Kaufman has led the transformation of the consumer products business, unifying the organization by placing the full power of the Paramount ecosystem behind its most valuable IP. Her commitment to transformation, innovation and brand building has led to some of the most groundbreaking partnerships in the company’s history, including cutting-edge co-branded collaborations with the biggest names in social media. Kaufman was also responsible for Viacom’s first direct-to-consumer e-commerce site in 2019 – The SpongeBob Shop – and has since led the expansion to additional online direct-to-consumer business for merchandise tied to various top CBS and Showtime programming, including similar standalone initiatives for brands such as Star Trek, South Park and MTV.

Prior to being named the President of Global Consumer Products and Experiences, Kaufman served as President of Consumer Products & Chief Marketing Officer for Nickelodeon where she was responsible for building some of Nickelodeon’s most memorable franchises ranging from PAW Patrol to SpongeBob SquarePants, shepherding them through important tentpole campaigns and milestone celebrations.

Before joining Nickelodeon in 1997, Kaufman held positions at Turner International, Equity Marketing and Grey Advertising. She earned her Bachelor of Arts in Public Communication from The American University in Washington D.C. and was awarded an Honorary Doctor of Humane Letters from The American University in 2019. A committed advocate for gender equality and diversity and inclusion, Kaufman serves on the board of the Rock and Roll Hall of Fame Foundation, as well as Bottomless Closet, a nonprofit that prepares women for workplace success, and the Pace Women’s Justice Center.

Paramount Global (NASDAQ: PARA, PARAA) is a leading global media and entertainment company that creates premium content and experiences for audiences worldwide. Driven by iconic studios, networks and streaming services, Paramount’s portfolio of consumer brands includes CBS, Showtime Networks, Paramount Pictures, Nickelodeon, MTV, Comedy Central, BET, Paramount+, Pluto TV and Simon & Schuster, among others. Paramount delivers the largest share of the U.S. television audience and boasts one of the industry’s most important and extensive libraries of TV and film titles. In addition to offering innovative streaming services and digital video products, the company provides powerful capabilities in production, distribution, and advertising solutions.

For more information about Paramount, please visit www.paramount.com and follow @ParamountCo on social platforms.

PARA-IR

Logo – https://mma.prnewswire.com/media/1747626/Paramount_Logo.jpg

Company has taken part in the Annual Scientific Meeting & Clinical Lab Expo since 2007

This year’s event showcased its In-life PCR campaign and STARlet-AIOS

Seegene also displayed Novaplex assays, including a test for detecting the monkeypox virus

SEOUL, South Korea, July 29, 2022 /PRNewswire/ — Seegene Inc. (096530), South Korea’s leading molecular diagnostics company, took part in the 2022 American Association of Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo in Chicago between July 26-28. Seegene showcased its ‘In-life PCR’ campaign and its automated PCR Solution ‘STARlet-AIOS,’ as well as a suite of Novaplex assays, including a test for detecting the monkeypox virus.

The AACC meeting, now in its 74^th year, is the world’s largest gathering for the clinical laboratory and diagnostics industry. More than 200 global companies participated in this year’s event. Seegene has taken part since 2007.

In-life PCR: Keeping communities safe through regular testing

Seegene’s In-life PCR campaign is a global initiative that emphasizes regular testing of COVID-19, influenza, and cold viruses to identify infected individuals with mild or no symptoms. This, in turn, may help curb widespread transmissions within communities. The campaign will target venues that require face-to-face interactions, such as schools, workplaces, and nursing homes.

Seegene will use the Allplex SARS-CoV-2/FluA/FluB/RSV Assay, which can simultaneously detect COVID-19, flu A and B, and respiratory syncytial virus (RSV), and will provide the necessary PCR instruments.

At the AACC, Seegene shared the campaign’s mission with participants and potential partners. The company recently partnered with a test center in Vietnam to launch the campaign and is working to expand the initiative to other regions, including Europe and the Middle East.

Enabling PCR testing at small clinics with fully automated STARlet-AIOS

Seegene’s STARlet-AIOS (All-in-One System) will provide “hands-free” PCR workflows, from nucleic acid extraction to result analysis. It is a fully automated (sample in – result out) system that can be operated by those with minimal PCR experience.

STARlet-AIOS is compatible with a wide range of Seegene’s syndromic assays that can simultaneously test for multiple targets with just a single tube. The company has obtained EU-approval for over 30 tests that can detect COVID-19 and other respiratory illnesses, human papillomavirus (HPV), other sexually transmitted infections (STIs), gastrointestinal infections (GIs), and drug resistance (DR).

STARlet-AIOS, which has a smaller footprint compared to other solutions in the market, is composed of independent and detachable PCR component instruments. Test centers can purchase the full set or modify their systems by adding detachable modules. The latter can be an eco-friendly option as it doesn’t require additional resources or manufacturing.

The modular nature of the system also makes maintenance convenient, while authorization procedures are easier as it combines pre-approved instruments. It is the world’s first “assembled” solution that enables automated syndromic testing.

These features will allow small hospitals, local clinics, and public health centers to integrate STARlet-AIOS into their workflows. The STARlet-AIOS is expected to play a pivotal role in the expansion of Seegene’s In-life PCR campaign.

Also, at the 2022 AACC, Seegene displayed its Research Use Only (RUO) product line, Novaplex, for the U.S. market. This portfolio includes a dedicated test for detecting the monkeypox virus.

Seegene recently strengthened its U.S. leadership team as part of efforts to extend its global success to the U.S. market.

Logo – https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg